코로나19
백신 및 치료제
현황

코로나19백신 및 치료제가
최근 신약 발굴의 주를 이루었습니다.

보고서 다운로드

Vaccine/Therapy Name Type Countries Manufacturer
Ad5-nCoV (Convidecia™) Single-dose recombinant viral vector vaccine Beijing Institute of Biotechnology of the Academy of Military Medical Sciences, CanSino Biologics Inc.
AZD-1222 Two-dose recombinant viral vector vaccine AstraZeneca plc, University of Oxford
Bamlanivimab (LY-3819253, LY-CoV555) MAb Abcellera Biologics Inc., Eli Lilly and Co.
Baricitinib (OLUMIANT®) Janus kinase inhibitor Abcellera Biologics Inc., Eli Lilly and Co.
BBIBP-CorV Two-dose inactivated vaccine Beijing Institute of Biological Products Co. Ltd, Henan Provincial Center for Disease Control and Prevention
Casirivimab and imdevimab MAb Regeneron Pharmaceuticals Inc., Roche
CoronaVac Two-dose inactivated vaccine Bio Farma, Dynavax Technologies, Instituto Butantan, Sinovac Biotech Ltd.
COVAXIN® Two-dose inactivated vaccine Bharat Biotech International, Ocugen Inc.
CoviVac Two-dose inactivated vaccine Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Science
Dexamethasone phosphate (DEXAVAN) Corticosteroid Bausch Health, Oxford University
EpiVacCorona Two-dose synthetic peptide State Research Center of Virology and Biotechnology VECTOR
Etesevimab (LY-CoV016) MAb Abcellera Biologics Inc., Eli Lilly and Co., Shanghai Junshi Biosciences Co. Ltd.
Favipiravir (Reeqonus™, Avigan®) Broad-spectrum antiviral; Viral RNA-dependent, RNA polymerase inhibitor Appili Therapeutics, Dr. Reddy's Laboratories Ltd., Fujifilm Holdings, Fujifilm Toyama Chemical Co. Ltd., Genentech, Glenmark Pharmaceuticals Ltd., Medivector Inc., Sihuan Pharmaceutical Holdings Group, Zhejiang Hisun Pharmaceutical Co. Ltd.
Gam-COVID-Vac Two-dose recombinant viral vector vaccine Gamaleya Research Institute, Sputnik V
JNJ-78436735 (Ad26.COV2-S) Single-dose recombinant viral vector vaccine Biomedical Advanced Research and Development Authority (BARDA), Catalent, Emergent Biosolutions®, Grand River Aseptic Manufacturing, Johnson & Johnson
mRNA-1273 (TAK-919; elasomeran; SPIKEVAC™) Two-dose, lipid nanoparticle RNA vaccine Catalent, Ginkgo Bioworks, Moderna Therapeutics, Recipharm, Takeda Pharmaceutical Co. Ltd.
Regdanvimab (Regkirona; CT-P59) MAb Celltrion
Remdesivir (VEKLURY®) Broad-spectrum antiviral; Viral RNA-dependent, RNA polymerase inhibitor Cipla Limited, Dr. Reddy's Laboratories Ltd., Gilead Sciences Inc., Hetero
Sotrovimab (GSK4182136, VIR-7831, VIR-7832) MAb Biogen Inc., GlaxoSmithKline plc, National Institute of Allergy and Infectious Diseases (NIAID), Samsung Biologics, Vir Biotechnology, Wuxi Biologics, Xencor Inc.
Tixagevimab and cilgavimab (AZD-7442; combination of AZD-8895 and AZD-1061; Evusheld) MAb AstraZeneca plc
Tocilizumab (Actemra; Roactemra) MAb Chugai, Genentech
Tozinameran (BNT-162b2, COMIRNATY®) Two-dose, lipid nanoparticle RNA vaccine BioNTech SE, Comirnaty, Fosun Pharma, Pfizer Inc.
ZF2001 (RBD-dimer, Zifivax) Three-dose protein subunit Anhui Zhifei Longcom Biopharmaceutical Co. Ltd., Chinese Academy of Sciences
ZyCov-D Three-dose DNA Zydus Cadila Healthcare Ltd.

리소스

No items found

혁신에서 수익에 이르기까지

클래리베이트의 글로벌 인텔리전스, 고급 분석 및 글로벌 전문가 그룹을 만나보세요.

클래리베이트 컨설턴트에게 문의하세요